« Back to Record
Awada, A., Hendlisz, A., Gil, T., Schwartz, B., Bartholomeus, S., de Valeriola, D., Brendel, E., Haase, C. G., & Piccart-Gebhart, M. (2004). A phase I study of BAY 43-9006, a novel Raf kinase and VEGFR inhibitor, in combination with taxotere in patients with advanced, solid tumors. European Journal of Cancer. Vol. 2 (p. 114) 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics(2004).
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/278708



